Microbix Biosystems (MBX) Competitors C$0.34 -0.01 (-2.82%) As of 12:26 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock MBX vs. BCT, IPA, APS, FRX, TH, SCYB, COM, NVH, IGX, and MDNAShould you be buying Microbix Biosystems stock or one of its competitors? The main competitors of Microbix Biosystems include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Aptose Biosciences (APS), Fennec Pharmaceuticals (FRX), Theratechnologies (TH), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), and Medicenna Therapeutics (MDNA). These companies are all part of the "biotechnology" industry. Microbix Biosystems vs. BriaCell Therapeutics ImmunoPrecise Antibodies Aptose Biosciences Fennec Pharmaceuticals Theratechnologies Scythian Biosciences 138267 (COM.TO) Novoheart IntelGenx Technologies Medicenna Therapeutics BriaCell Therapeutics (CVE:BCT) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation. Does the media refer more to BCT or MBX? In the previous week, Microbix Biosystems' average media sentiment score of 0.00 beat BriaCell Therapeutics' score of -0.66 indicating that Microbix Biosystems is being referred to more favorably in the news media. Company Overall Sentiment BriaCell Therapeutics Negative Microbix Biosystems Neutral Is BCT or MBX more profitable? Microbix Biosystems has a net margin of 13.86% compared to BriaCell Therapeutics' net margin of 0.00%. Microbix Biosystems' return on equity of 12.65% beat BriaCell Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets BriaCell TherapeuticsN/A N/A N/A Microbix Biosystems 13.86%12.65%3.82% Do institutionals & insiders believe in BCT or MBX? 0.4% of Microbix Biosystems shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, BCT or MBX? Microbix Biosystems has higher revenue and earnings than BriaCell Therapeutics. BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19Microbix BiosystemsC$24.42M1.91C$3.39MC$0.0313.52 Does the MarketBeat Community favor BCT or MBX? Microbix Biosystems received 30 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. Likewise, 70.71% of users gave Microbix Biosystems an outperform vote while only 68.97% of users gave BriaCell Therapeutics an outperform vote. CompanyUnderperformOutperformBriaCell TherapeuticsOutperform Votes4068.97% Underperform Votes1831.03% Microbix BiosystemsOutperform Votes7070.71% Underperform Votes2929.29% SummaryMicrobix Biosystems beats BriaCell Therapeutics on 11 of the 11 factors compared between the two stocks. Get Microbix Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBX vs. The Competition Export to ExcelMetricMicrobix BiosystemsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$46.76MC$120.69MC$5.40BC$5.61BDividend Yield2.30%3.69%5.44%6.83%P/E Ratio13.523.0122.1329.97Price / Sales1.914,175.59393.25599.74Price / Cash4.1313.0238.2083.07Price / Book1.7234.466.783.72Net IncomeC$3.39M-C$90.45MC$3.21BC$300.28M7 Day Performance1.43%1.24%4.64%2.12%1 Month Performance-14.46%-3.99%-6.47%-2.34%1 Year Performance5.97%89.74%16.09%13.08% Microbix Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBXMicrobix BiosystemsN/AC$0.35-2.8%N/A+6.0%C$45.44MC$24.42M13.14N/ABCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195News CoverageIPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownAPSAptose BiosciencesN/AC$3.28+0.9%N/A-93.4%C$141.23MN/A-0.6531Gap UpFRXFennec PharmaceuticalsN/AC$7.08flatN/AN/AC$136.54MC$34.86M-119.9310THTheratechnologiesN/AC$3.79+6.8%N/A+97.9%C$120.92MC$52.22M-42.90103SCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpMDNAMedicenna TherapeuticsN/AC$1.05-0.9%N/A-32.9%C$78.56MC$4,868.39-2.8920Gap Up Related Companies and Tools Related Companies BriaCell Therapeutics Competitors ImmunoPrecise Antibodies Competitors Aptose Biosciences Competitors Fennec Pharmaceuticals Competitors Theratechnologies Competitors Scythian Biosciences Competitors 138267 (COM.TO) Competitors Novoheart Competitors IntelGenx Technologies Competitors Medicenna Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:MBX) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbix Biosystems Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbix Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
